PL02.08 Registrational Results of LIBRETTO-001: A Phase 1/2 Trial of LOXO-292 in Patients with RET Fusion-Positive Lung CancersAlexander Drilon, Kristoffer Staal Rohrberg, Oliver Gautschi et al.|Journal of Thoracic Oncology|2019Cited by 81
IMPROVE: a feature model to predict neoepitope immunogenicity through broad-scale validation of T-cell recognitionAnnie Borch, Sine Reker Hadrup, Ibel Carri et al.|Frontiers in Immunology|2024Cited by 26